Home › USFDA Tracker › Divi's Laboratories
Divi's Laboratories — USFDA Status
Inspections, Form 483 observations, OAI classifications, warning letters, import alerts and approvals for Divi's Laboratories (NSE: DIVISLAB, BSE: 532488), from US FDA records and exchange filings.
80
Compliance score (5 years) · how
2
USFDA-inspected plants on record
0
OAI classifications (5y)
0
Form 483s on record (5y)
0
Open warning letters
Latest USFDA record: USFDA inspection classified NAI — 14 Nov 2025 (Nalgonda plant). Source: FDA Data Dashboard.
USFDA events by year
2024
2025
NAIVAIForm 483OAIWarning letterImport alertUS approval
Plants
| Plant | FEI | Latest result | Last inspection | History (newest first) |
|---|---|---|---|---|
| Nalgonda Divi's Laboratories Limited, Unit-1 |
3003131136 | NAI | 14 Nov 2025 | |
| Visakhapatnam District Divi's Laboratories Ltd. (Unit II) |
3004149463 | VAI | 19 Jul 2024 |
Full USFDA timeline
14 Nov 2025
NAI — clean
USFDA inspection classified NAI
Nalgonda · FEI 3003131136 · Divi's Laboratories Limited, Unit-1, Nalgonda — Drug Quality Assurance (Drugs)
Source: FDA Data Dashboard ↗
19 Jul 2024
VAI — minor issues
USFDA inspection classified VAI
Visakhapatnam District · FEI 3004149463 · Divi's Laboratories Ltd. (Unit II), Visakhapatnam District — Drug Quality Assurance (Drugs)
Source: FDA Data Dashboard ↗
📎 Cite this data: Source: PharmaRoz analysis of FDA inspection data and exchange filings, updated 12 Nov 2026 — https://pharmaroz.com/company/divis